Integrated Advisors Network’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Integrated Advisors Network's IBB Position: Q2 2026 in Review
Integrated Advisors Network reduced its iShares Biotechnology ETF (IBB) stake by 46% in Q2 2026, selling an estimated $174K and leaving 1,180 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #636.
Integrated Advisors Network first reported a position in IBB in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.9M in Q2 2021. 958 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Integrated Advisors Network held 1,180 shares of iShares Biotechnology ETF worth $224K as of Q2 2026.
- Integrated Advisors Network sold 1,015 iShares Biotechnology ETF shares in Q2 2026, an estimated $174K.
- iShares Biotechnology ETF made up 0.01% of Integrated Advisors Network's portfolio in Q2 2026, its #636 holding.
- Integrated Advisors Network first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 20 quarters since.
- Integrated Advisors Network's iShares Biotechnology ETF position peaked at $1.9M in Q2 2021.
- 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Integrated Advisors Network's 13F filing for Q2 2026, filed 11 Aug 2026.